CONFERENCE REGISTRATION

Standard Package:

  • Registration fee for Non Members: € 375,00 + VAT 22%

  • Sin and EAN Members: special rate at € 187,50 + VAT 22%

Registration fee includes: conference kit, admission to all the scientific sessions, lunch and coffee breaks.

CONFERENCE VENUE

Palazzo Blu
Lungarno Gambacorti, 9
56125 Pisa
www.palazzoblu.it

OFFICIAL LANGUAGE

English is the official language of the Conference. No simultaneous translation will be provided.

CONTINUING MEDICAL EDUCATIONS ( CME )

Italian participants will receive Italian CME credits (ECM).

CONFERENCE ORGANIZERS

Ubaldo Bonuccelli (Pisa - Italy)
Sandro Sorbi (Firenze - Italy)

CONFERENCE

The 5th International Conference on New Therapies for Parkinson and Dementias will take place in Pisa on September 25, 2017. The conference will bring together international experts of neurodegenerative diseases coming from the academic world, hospital centres and pharmaceutical industry. The meeting will focus on the new possibilities of preclinical and early diagnosis, and on the more innovative pharmacological and non-pharmacological therapies.The results of clinical trials will be evaluated and discussed, as well as ongoing studies and the expected outcomes, drugs' pipeline, non-pharmacological therapies, perspectives on biomarkers and on future diagnostic-therapeutic scenario and unmet needs of patients with parkinsonian syndromes and dementias.

PROGRAMME

Programme Download

PAST EDITIONS

Programme 2016

Programme 2015

Programme 2014

Programme 2013

TOPICS

  • Basic science: what’s new

  • Animal Models of PD

  • Proteinopathies

  • Does Parkinson’s disease start in the gut?

  • Early diagnosis: IMAGING

  • Molecular imaging in PD: new insights

  • Tau-PET in neurodegenerative diseases. Where are we?

  • Neuroinflammation

  • AD-PD: Advanced statistical techniques for an unbiased categorization

  • Development of precision neurology for AD and other neurodegenerative diseases

  • New Therapeutical Strategies

  • PD-MAO B inhibition: an overview

  • PD-COMT inhibition: recent advances

  • Clinical Trials in Parkinsonisms: problems and perspectives

  • Clinical Trials in dementias: problems and perspectives

  • Can we change the history of MCI progression? The LipiDiDiet study

  • Neuropsychiatry of Parkinson’s Disease

ABOUT PISA

Pisa is a city in Tuscany, Central Italy, straddling the Arno just before it empties into the Ligurian Sea. It is the capital city of the Province of Pisa. Although Pisa is known worldwide for its leaning tower (the bell tower of the city’s cathedral), the city of over 90,834 residents (around 200,000 with the metropolitan area) contains more than 20 other historic churches, several medieval palaces and various bridges across the Arno. Much of the city’s architecture was financed from its history as one of the Italian maritime republics.
The city is also home of the University of Pisa, which has a history going back to the 12th century and also has the Scuola Normale Superiore di Pisa, founded by Napoleon in 1810, and its offshoot, the Sant’Anna School of Advanced Studies as the best sanctioned Superior Graduate Schools in Italy.

ORGANIZING SECRETARIAT

First Class S.r.l. Meetings and Conferences
Viale Italia, 173 - 57127 Livorno
Via Malasoma, 14/16 - 56121 Pisa - Italy
Ph: +39 0586 84 98 11
Fax: + 39 0586 34 99 20
Email: veronica.trastulli@fclassevents.com

First Class S.r.l.

ENDORSEMENTS

This meeting has been endorsed by the European Academy of Neurology

European Academy of Neurology



4th Congress of the European Academy of Neurology (EAN)
Lisbon, Portugal
June 16-19, 2018

Website: www.ean.org/lisbon2018
Contact: lisbon2018@ean.org